A discoverer of synthetic antibodies is asking Food and Drug Administration for clearance to begin a clinical trial of a Covid-19 antibody cocktail therapy. . . . → Read More: Covid-19 Antibody Cocktail Trial Request Filed
|
|||||
       
  |
A developer of synthetic RNA products is partnering with Samsung Biologics to manufacture Covid-19 vaccines made with messenger RNA. . . . → Read More: Samsung, Biotech Partner on mRNA Vaccine Production 
A biotechnology company is licensing five of its vaccines for cancer and infectious diseases to Regeneron Pharmaceuticals in a deal valued at nearly $1 billion. . . . → Read More: Regeneron Gains Cancer, Infectious Disease Immunotherapies  Comments are closed  Intellectual property, Joint ventures/collaborations  biomedical, biotechnology, cancer, Covid-19, equity, Europe, investment, licensing, life sciences, pharmaceuticals 
A new business is underway to develop and commercialize treatments for Covid-19 and other diseases based on synthetic antibody proteins. . . . → Read More: New Company to Develop Synthetic Antibody Therapies One comment - (Comments are closed) Finance, Intellectual property, New products biomedical, biotechnology, Covid-19, entrepreneurs, equity, genomics, investment, licensing, pharmaceuticals, venture capital 
Data released by the U.S. Centers for Disease Control and Prevention show new Covid-19 infections are concentrated largely among unvaccinated people. . . . → Read More: Infographic – Unvaccinated Driving New Covid-19 Cases Comments are closed Business conditions, Regulations biomedical, Covid-19, health care, pharmaceuticals, statistics 
Biomedical engineers found a chip device with intestinal tissue can simulate coronavirus infections and symptoms in the gut, and test possible treatments. . . . → Read More: Chip Device Simulates Coronavirus Gut Symptoms Comments are closed New products biomedical, Covid-19, engineering, life sciences, medical device, physical sciences, preclinical, university 
A developer of synthetic bio-based products from engineered yeast cells is joining with an immunotherapy drug maker to produce a stable RNA Covid-19 vaccine. . . . → Read More: Joint Venture to Develop Stable RNA Covid-19 Vaccine Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, cancer, chemistry, Covid-19, licensing, life sciences, manufacturing, nanotechnology, pharmaceuticals, physical sciences 
As the world’s economy recovers from pandemic restrictions, rising carbon dioxide emissions are also contributing to the global climate crisis. . . . → Read More: Infographic – Post-Covid CO2 Emissions Rebound Comments are closed Business conditions chemistry, Covid-19, economics, energy, physical sciences, statistics 
A deep and multi-variable analysis of patients with serious Covid-19 respiratory symptoms finds the condition associated with abnormal expression of one gene. . . . → Read More: AI Analysis Finds Serious Covid-19 Genetic Driver One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, Covid-19, Europe, genomics, life sciences, mathematics, medical device, physical sciences, university 
As the world struggles to overcome the Covid-19 pandemic, author Michael Lewis tells how the U.S. first struggled to identify and contain the virus. . . . → Read More: Book Review – The Premonition: A Pandemic Story Comments are closed Business conditions biomedical, Covid-19, economics, health care, life sciences, mathematics, medical device, pharmaceuticals, physical sciences, software, special, statistics |
|
|||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
